Jill Carley is a pharmacist who is specialized in Ambulatory Care in Bellville, Texas. Patients can reach her at 250 W Palm St, Bellville or contact her on 979-865-3696. Active license number of Jill Carley is 38679 for Ambulatory Care in Texas. Jill Carley is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Jill Carley speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Jill Carley
Specialization:
Ambulatory Care
Credentials:
RPH
Gender:
Female
Location:
250 W Palm St, Bellville, Texas, 77418-1361
Phone:
979-865-3696
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Jill Carley are as mentioned below.
NPI Number:
1740871359
NPI Enumeration Date:
27 Jan, 2021
NPI Last Update On:
27 Jan, 2021
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jill Carley are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
38679
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
250 W Palm St, Bellville, Texas
Zip:
77418-1361
Phone Number:
979-865-3696
Fax Number:
--
Patients can reach Jill Carley at 250 W Palm St, Bellville, Texas or can call on phone at 979-865-3696.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.